At the bench: preclinical rationale for CTLA-4 and PD-1 blockade as cancer immunotherapy (Q36935749)
Jump to navigation
Jump to search
scientific article published on 26 April 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | At the bench: preclinical rationale for CTLA-4 and PD-1 blockade as cancer immunotherapy |
scientific article published on 26 April 2013 |
Statements
At the bench: preclinical rationale for CTLA-4 and PD-1 blockade as cancer immunotherapy (English)
26 April 2013
2 references
2 references
2 references
1 reference
1 reference
1 reference
1 reference